Table 1.
Patient Characteristics and Outcomes.
| Patient No. | Age | Sex | Duration of Follow-up after Transplantation | Serum Creatinine Level at Last Observation | Interval since Discontinuation of Antirejection Drugs at Last Observation* |
|---|---|---|---|---|---|
| yr | mo | mg/dl | mo | ||
| 1 | 48 | M | 42 | 1.3 | 36 |
| 2 | 39 | F | 68 | 0.9 | |
| 3 | 24 | M | 62 | 1.3 | |
| 4 | 52 | M | 46 | 1.4 | 28 |
| 5 | 34 | M | 44 | 1.2 | 36 |
| 6 | 61 | F | 43 | 1.2 | |
| 7 | 23 | F | 39 | 0.7 | 28 |
| 8 | 33 | M | 36 | 0.9 | 30 |
| 9 | 29 | F | 30 | 1.0 | |
| 10 | 52 | F | 29 | 0.9 | 17 |
| 11 | 37 | F | 21 | 1.0 | 14 |
| 12 | 36 | F | 18 | 1.4 | 12 |
*
Patients for whom no months are shown continued to receive immunosuppressive drugs (Patient 2, mycophenolate mofetil and cyclosporine; Patient 3, cyclosporine alone; Patient 6, mycophenolate mofetil and tacrolimus; and Patient 9, tacrolimus alone). To convert values for creatinine to micromoles per liter, multiply by 88.4.